Paper41234828
Liriopesides B inhibits proliferation and metastasis and induces apoptosis of oral squamous cell carcinoma via the PI3K/Akt/mTOR signaling pathway.
Wei J and 6 others. Transl Cancer Res, 2025. Cited by 0 papers, by iCite.
Cite this record
ConductScience Library. Liriopesides B inhibits proliferation and metastasis and induces apoptosis of oral squamous cell carcinoma via the PI3K/Akt/mTOR signaling pathway. Papers, record 41234828. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/41234828
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Liriopesides B inhibits proliferation and metastasis and induces apoptosis of oral squamous cell carcinoma via the PI3K/Akt/mTOR signaling pathway.
- PubMed
Topics0
NLM's MeSH indexing of the paper, its major topics first.
None in this release.
References39
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 40466285 | An exploration of molecular signaling in drug reprocessing for Oral Squamous Cell Carcinoma. | Eur J Med Chem | 2025 | https://conductscience.org/library/papers/40466285 | PubMed |
| 2 | 21943236 | Apoptosis in cancer: from pathogenesis to treatment. | J Exp Clin Cancer Res | 2011 | https://conductscience.org/library/papers/21943236 | PubMed |
| 3 | 32099325 | Genipin Induces Autophagy and Suppresses Cell Growth of Oral Squamous Cell Carcinoma via PI3K/AKT/MTOR Pathway. | Drug Des Devel Ther | 2020 | https://conductscience.org/library/papers/32099325 | PubMed |
| 4 | 31063755 | Epithelial-Mesenchymal Plasticity in Cancer Progression and Metastasis. | Dev Cell | 2019 | https://conductscience.org/library/papers/31063755 | PubMed |
| 5 | 28368610 | Bax Activation Blocks Self-Renewal and Induces Apoptosis of Human Glioblastoma Stem Cells. | ACS Chem Neurosci | 2018 | https://conductscience.org/library/papers/28368610 | PubMed |
| 6 | 28550454 | Oncogenic Roles of the PI3K/AKT/mTOR Axis. | Curr Top Microbiol Immunol | 2017 | https://conductscience.org/library/papers/28550454 | PubMed |
| 7 | 40699851 | Early Molecular Diagnosis and Comprehensive Treatment of Oral Cancer. | Curr Issues Mol Biol | 2025 | https://conductscience.org/library/papers/40699851 | PubMed |
| 8 | 37913583 | Inhibitory effect of liriopesides B in combination with gemcitabine on human pancreatic cancer cells. | Bioorg Chem | 2024 | https://conductscience.org/library/papers/37913583 | PubMed |
| 9 | 28538838 | Relationship between matrix metalloproteinases and the occurrence and development of ovarian cancer. | Braz J Med Biol Res | 2017 | https://conductscience.org/library/papers/28538838 | PubMed |
| 10 | 27501444 | Cellular and Molecular Mechanisms of MT1-MMP-Dependent Cancer Cell Invasion. | Annu Rev Cell Dev Biol | 2016 | https://conductscience.org/library/papers/27501444 | PubMed |
| 11 | 30519710 | Targeted disruption of PI3K/Akt/mTOR signaling pathway, via PI3K inhibitors, promotes growth inhibitory effects in oral cancer cells. | Cancer Chemother Pharmacol | 2019 | https://conductscience.org/library/papers/30519710 | PubMed |
| 12 | 31542510 | Translational genomics and recent advances in oral squamous cell carcinoma. | Semin Cancer Biol | 2020 | https://conductscience.org/library/papers/31542510 | PubMed |
| 13 | 35119132 | Current perspectives on naturally occurring saponins as anticancer agents. | Arch Pharm (Weinheim) | 2022 | https://conductscience.org/library/papers/35119132 | PubMed |
| 14 | 37063281 | Effects of saponins from Chinese herbal medicines on signal transduction pathways in cancer: A review. | Front Pharmacol | 2023 | https://conductscience.org/library/papers/37063281 | PubMed |
| 15 | 40549116 | Trends in immunotherapy for oral squamous cell carcinoma. | Cell Oncol (Dordr) | 2025 | https://conductscience.org/library/papers/40549116 | PubMed |
| 16 | 21376230 | Hallmarks of cancer: the next generation. | Cell | 2011 | https://conductscience.org/library/papers/21376230 | PubMed |
| 17 | 32582970 | Liriopesides B from Liriope spicata var. prolifera inhibits metastasis and induces apoptosis in A2780 human ovarian cancer cells. | Mol Med Rep | 2020 | https://conductscience.org/library/papers/32582970 | PubMed |
| 18 | 38128017 | Correction: Fuling Granule, a Traditional Chinese Medicine Compound, Suppresses Cell Proliferation and TGFβ-Induced EMT in Ovarian Cancer. | PLoS One | 2023 | https://conductscience.org/library/papers/38128017 | PubMed |
| 19 | 32705266 | Liriopesides B induces apoptosis and cell cycle arrest in human non‑small cell lung cancer cells. | Int J Mol Med | 2020 | https://conductscience.org/library/papers/32705266 | PubMed |
| 20 | 40381609 | The effects of ketone bodies and ketogenesis on the PI3K/AKT/mTOR signaling pathway: A systematic review. | Nutr Res | 2025 | https://conductscience.org/library/papers/40381609 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Cited by
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/41234828
GET https://conductscience.org/api/papers/v1/41234828/references?page=2